Please login to read the full article.
Scrip Regulatory Affairs
Govt committee makes recommendations for improving New Zealand's clinical trials environment
09 June 2011
Vibha Sharma
Please login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- Australian Senate panel inquiry expresses shock at patient experiences with DePuy hip devices; calls for stricter regulations
- UK PIP report highlights need to improve adverse incident reporting; registries urged
- France votes for more regulatory transparency, tighter safety monitoring and tougher promotion controls
- April brings in new French healthcare laws: update on the implementing rules
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
